At the Middlesex Health Cancer Center, we're constantly researching cutting-edge, innovative treatment options. This allows us to contribute to tests of the effectiveness of new drugs and treatments to find better ways to treat cancer and improve the quality of life for our patients. Patients who volunteer to take part in clinical research trials play a very important role in advancing our knowledge of how cancer responds to new treatments, and this knowledge helps us tailor cancer treatment to better target the cancer and increase the likelihood of a response.
We participate in a wide variety of clinical trials, including National Cancer Institute-sponsored National Clinical Trials Network (NCTN) studies and industry-sponsored research. Our membership in The Alliance for Clinical Trials in Oncology, NRG Oncology, and Academic and Community Cancer Research United (ACCRU) gives us expanded access to oncology clinical trials from across the United States and around the world.
Our Clinical Trials Office (CTO) includes two certified research coordinators, a research nurse, and a certified regulatory specialist, all of whom work with our oncologists to ensure that all patients are:
- screened for study eligibility
- provided with education and support before, during, and after treatment
- included in research that is conducted according to federal regulations